Norpharma competitive analysis

Latest publications and patents of Norpharma New

Explore the latest publications and patents granted to Norpharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 28, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Norpharma

May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of BuprenorphineRevoked

Explore Norpharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine3

Latest PTAB cases involving Norpharma

Discover the latest PTAB cases involving Norpharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Norpharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
NORPHARMA - 3 - - Non-Active
GALLAFENT1 - - - Highly Aggressive
HEXAL573 - - Highly Aggressive
TESA LABTEC1 - - - Highly Aggressive